1ALLHAT Officers and Coordinators for the ALLHAT Collaborative Reserch Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic [J]. JAMA. 2002. 288(23):2981-2997 被引量：1
2Sharabi Y, Illan R, Kamari Y, et al. Diuretic induced hyponatraemia in elderly hypertensive women [J]. J Hum Hypertens,2002,16(9) :631-635. 被引量：1
3Gress TW, Nieto FJ, Shahar E, et al. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus[J]. N Engl J Med,2000,342(13) .-905-912. 被引量：1
4Rosei EA,Dal Palu C, Leonetti G, et al. Clinical results of the Verapamil in Hypertension and Atherosclerosis Study [J]. J Hypertens, 1997,15(11) : 1337-1344. 被引量：1
5Weidmann P. Metabolic profile of indapamide sustained-release in patients with hypertension: data from three randomised double-blind studies [J]. Drug Safety, 2001, 24 ( 15 ) : 1155- 1165. 被引量：1
7Sharma AM, Pischon T, Hardt S, et al. Hypothesis: Beta- adrenergic receptor blockers and weight gain: a systematic analysis[J]. Hypertension, 2001,37 (2) : 250-254. 被引量：1
8Pischon T, Sharma AM. Use of beta-blocker in obesity hypertension: potential role of weight gain[J]. Obes Rev, 2001,2 (4) : 757-780. 被引量：1
9Fogari R, Zoppi A, Corradi L, et al. Beta-blocker effects on plasma lipids during prolonged treatment of hypertensive patients with hypercholesterolemia [J]. J Cardiovasc Pharmacol, 1999,33 (4) : 534-539. 被引量：1
10Lakshman MR, Reda DJ, Materson BJ, et al. Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension[J]. Arch Intern Med,1999,159(6) :551-558. 被引量：1
9van Dijk MM, de la Rosette JJ,Michel MC.Effects of alpha(1)-adrenoceptor antagonists on male sexual function[J].Drugs,2006,66 (3):287-301. 被引量：1
10Lindholm LH,Carlberg B,Samuelsson O.Should beta blockers remain first choice in the treatmen of primary hypertension? A metaanalysis[J].Lancet,2005,366(9496): 1545-1553. 被引量：1
